# Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

> **NCT00945841** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 126 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** inactivated split influenza vaccine

## Key facts

- **NCT ID:** NCT00945841
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945841, "Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00945841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*